Locost Opposition, Lenacapavir, (In201917006277)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
AIDS HEALTHCARE FOUNDATION [AHF] opposition, Lenacapavir, (202017010006)
Countries: India Date: 2025
-
AIDS HEALTHCARE FOUNDATION [AHF] opposition, Lenacapavir, (202017007904)
Countries: India Date: 2025
-
Vietnam Network of People Living with HIV (VNP+) opposition, Rilpivirine, (PCT/US2021/072453)
Countries: Viet Nam Date: 2025
-
Thai Network of People Living with HIV/AIDS (TNP+) opposition, Rilpivirine, (WO/2012/068535)
Countries: Thailand Date: 2025
-
People PLUS opposition, Rilpivirine, (EA202391454)
Countries: Europe (EPO) Date: 2025
-
Fundación Grupo Efecto Positivo opposition, Dolutegravir pediatric combination, (P20210101732 (AR122720A1))
Countries: Argentina Date: 2025
-
Fundación Grupo Efecto Positivo (FGEP) opposition, Dolutegravir pediatric dispersible tablet, (P20210101730 (AR122718A1) )
Countries: Argentina Date: 2025
-
Fundación ifarma opposition, Cabotegravir/rilpirivine pediatric, (NC2025/0004675)
Countries: Colombia Date: 2025
-
100 Percent Life opposition, GS-4182 (LEN prodrug), (a202403104)
Countries: Ukraine Date: 2025
-
Fundación Grupo Efecto Positivo (FGEP) opposition, Dolutegravir/Rilpivirine, (AR112213A1 (P20180101799) )
Countries: Argentina Date: 2025